OpenBilldrug price receipt

NADAC week of 2026-10-14

CHILD'S MULTI-SYMPTOM COLD LIQ

FDA nonproprietary name: dextromethorphan hbr, guaifenesin, phenylephrine hcl

For 118 mL

Pharmacies pay

$5.52 filed

118 × $0.04678 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$11.35 estimated

$5.52 + $0.83 (15%) + $5.00 fee per fill = $11.35

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

CHILD'S MULTI-SYMPTOM COLD LIQ is how the CMS NADAC file names this product. The FDA NDC Directory lists it as dextromethorphan hbr, guaifenesin, phenylephrine hcl, under the trade name “Leader Childrens Multi Symptom Cold”.

FDA gives its dosage form as liquid and its route as oral.

The labeler, the company named on the label, is CARDINAL HEALTH 110, LLC. DBA LEADER.

FDA lists it under 4 Established Pharmacologic Classes: alpha-1 Adrenergic Agonist, Expectorant, Sigma-1 Agonist and Uncompetitive N-methyl-D-aspartate Receptor Antagonist.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 70000-0629-01.

NADAC classes it as a generic drug (rate-setting class G), and marks it as sold over the counter.

What pharmacies pay

Pharmacies pay $5.52 for 118 mL (118 × $0.04678 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

The NDC

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name dextromethorphan hbr, guaifenesin, phenylephrine hcl with CHILD'S MULTI-SYMPTOM COLD LIQ.

ProductPharmacies pay per unitMedicare per unit
CHILD'S MULTI-SYMPTOM COLD LIQ this page
generic · liquid
$0.04678 per ML filed
eff. 2026-09-23
We don’t know yet
TUSNEL-DM PED 2.5-25-1.25 MG/ML
generic · solution/ drops
$0.27516 per ML filed
eff. 2026-09-23
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Compared with its class

Its NADAC price is $0.04678 per ML filed.

Of the 30 other products in FDA’s alpha-1 Adrenergic Agonist class priced per ML, 18 have a higher middle NADAC price and 12 a lower one. The one in the middle is POLYTUSSIN DM 7.5-5-12.5 MG/5 ML, at $0.0623 per ML filed (eff. 2026-09-23).

Of the 38 other products in FDA’s Expectorant class priced per ML, 4 have a higher middle NADAC price and 34 a lower one. The one in the middle is ROBAFEN DM 200-20 MG/20 ML LIQ, at $0.02069 per ML filed (eff. 2026-09-23).

Of the 63 other products in FDA’s Sigma-1 Agonist class priced per ML, 22 have a higher middle NADAC price and 41 a lower one. The one in the middle is GNP TUSSIN LONG-ACTING LIQUID, at $0.02263 per ML filed (eff. 2026-09-23).

Of the 63 other products in FDA’s Uncompetitive N-methyl-D-aspartate Receptor Antagonist class priced per ML, 22 have a higher middle NADAC price and 41 a lower one. The one in the middle is GNP TUSSIN LONG-ACTING LIQUID, at $0.02263 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 118 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 118 mL in one package for this product’s NDC (“1 BOTTLE in 1 CARTON (70000-0629-1) / 118 mL in 1 BOTTLE”), so the card starts at one package: 118 ML. Change it to match your prescription.